UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022341
Receipt number R000025457
Scientific Title A Multicenter, single-blind, randomized, parallel-group trial comparing Reinforced Reload with Tri-Staple with Tri-Staple during Distal Pancreatectomy
Date of disclosure of the study information 2016/05/18
Last modified on 2019/02/05 18:01:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Multicenter, single-blind, randomized, parallel-group trial comparing Reinforced Reload with Tri-Staple with Tri-Staple during Distal Pancreatectomy

Acronym

RETTS-DP trial

Scientific Title

A Multicenter, single-blind, randomized, parallel-group trial comparing Reinforced Reload with Tri-Staple with Tri-Staple during Distal Pancreatectomy

Scientific Title:Acronym

RETTS-DP trial

Region

Japan


Condition

Condition

Patients who underwent distal pancreatectomy

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate whetehr use of Reinforced Reload with Tri-Staple can significantly reduce the incidence of pancreatic fistula compared with Tri-Staple.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Incidence of Grade B/C postoperative pancreatic fistula within one month after surgery

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Use of Reinforced Reload with Tri-Staple

Interventions/Control_2

Use of Tri-Staple

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Patients who underwent distal pancreatectomy
2.Performance Status(PS)is 0-1 of Eastern Cooperative Oncology Group(ECOG)
3.more than 20 years old
4.Patients without distant metastasis excepting for liver metastasis from neouroendcrine tumor
5.Patients whose function of main organs is maintained.
6.Patients who canunderstand the contents of this clinical trial

Key exclusion criteria

1.patients with severe ischemic heart disease(NYHA > III)
2.patients with grade C of liver damage
3.patients requred countiuous oxygen administration due to severe lung disease
4.patients who received dialysis
5.patients with active cancer disease that may influence perioerative adverse events.
6.Patients who enable to enroll this trial due to their mental illness.
7.Patients who reject to enroll this trial

Target sample size

120


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshiaki Murakami

Organization

Hiroshima University Hospital

Division name

Gastrointestinal Surgery

Zip code


Address

1-2-3,KASUMI, MINAMI-KU, Hiroshima, JAPAN

TEL

082-257-5215

Email

mura777@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Naru Kondo

Organization

Hiroshima University Hospital

Division name

Gastrointestinal Surgery

Zip code


Address

1-2-3,KASUMI, MINAMI-KU, Hiroshima, JAPAN

TEL

082-257-5215

Homepage URL


Email

k-naru-surg@hiroshima-u.ac.jp


Sponsor or person

Institute

Hiroshima University Hospital

Institute

Department

Personal name



Funding Source

Organization

No

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

広島大学病院(広島県)


Other administrative information

Date of disclosure of the study information

2016 Year 05 Month 18 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 05 Month 11 Day

Date of IRB


Anticipated trial start date

2016 Year 05 Month 18 Day

Last follow-up date

2018 Year 01 Month 31 Day

Date of closure to data entry

2018 Year 02 Month 28 Day

Date trial data considered complete

2018 Year 04 Month 30 Day

Date analysis concluded

2018 Year 11 Month 30 Day


Other

Other related information



Management information

Registered date

2016 Year 05 Month 18 Day

Last modified on

2019 Year 02 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025457